I previously noted the prospect of two companies with PACs merging and what happens to their PACs. Now, Roche has signed a merger agreement with Genentech, Inc. Genentech’s PAC has about $88,000 cash on hand and the Roche, Inc. Good Government Fund has about $49,000.